ADAMTS13 unbound to larger von Willebrand factor multimers in cryosupernatant: implications for selection of plasma preparations for thrombotic thrombocytopenic purpura treatment.

Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto, Masanori; Fujimura, Yoshihiro

Hori, Yuji; Hayakawa, Masaki; Isonishi, Ayami; Soejima, Kenji; Matsumoto, Masanori; Fujimura, Yoshihiro.

Affiliation

Hori Y; Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Nara, Japan; The Chemo-Sero-Therapeutic Research Institute, Kikuchi, Kumamoto, Japan.

Transfusion ; 53(12): 3192-202, 2013 Dec.

Article in En | MEDLINE | ID: mdl-23560518

Subject(s)

ADAM Proteins/metabolism; Plasma Exchange/methods; Purpura, Thrombotic Thrombocytopenic/therapy; von Willebrand Factor/metabolism; ADAMTS13 Protein; Electrophoresis, Gel, Two-Dimensional; Humans

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Plasma Exchange / Purpura, Thrombotic Thrombocytopenic / Von Willebrand Factor / ADAM Proteins Limits: Humans Language: En Journal: Transfusion Year: 2013 Type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google